KALV
KalVista Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $562.32M | Price | $10.83 |
| Volume | 714.05K | Change | -0.73% |
| P/E Ratio | -3.1 | Open | $10.82 |
| Revenue | -- | Prev Close | $10.91 |
| Net Income | $-183.4M | 52W Range | $7.30 - $17.28 |
| Div Yield | N/A | Target | $30.67 |
| Overall | 28 | Value | 40 |
| Quality | 28 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyKalVista Pharmaceuticals Inc. (KALV) is a leading Healthcare company in the Biotechnology industry, currently trading at $10.91 with a market capitalization of $562.32 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 28.
Today's trading session shows KALV with a volume of 856K shares. The stock opened up 0.82% from yesterday's close of $10.97. Current analyst estimates project earnings of $-2.94 per share for this year, with next year targeting $-2.76.
KALV demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for KALV include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 181.1%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KALV | $10.83 | -0.7% | 714.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KalVista Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW